Literature DB >> 17616434

Epidemiological aspects and molecular characterization of Borrelia burgdorferi s.l. from southern Germany with special respect to the new species Borrelia spielmanii sp. nov.

Volker Fingerle1, Ulrike C Schulte-Spechtel, Eva Ruzic-Sabljic, Sarah Leonhard, Heidelore Hofmann, Klaus Weber, Kurt Pfister, Franc Strle, Bettina Wilske.   

Abstract

In 475 Borrelia-infected Ixodes ricinus (2155 ticks investigated) from southern Germany the most common Borrelia burgdorferi sensu lato species was B. garinii (34.3%) followed by B. afzelii (25.1%), B. burgdorferi sensu stricto (22.0%), and B. valaisiana (12.7%). B. spielmanii sp. nov. was detected in 5.9% of the 475 infected ticks. Hints for a focal distribution were found for B. spielmanii sp. nov. and B. garinii OspA type 4. In 242 patient isolates, dominance (66.9%) of B. afzelii for skin could be confirmed, while frequency of B. garinii in cerebrospinal fluid (CSF) isolates (51.1%) was comparable to the frequency in nymphal ticks (51.6%). Four patient isolates from southern Germany and two from Slovenia, all isolated from erythema migrans, could be assigned to B. spielmanii sp. nov. Within this new species high sequence identities were found for rrs, fla, and ospA while rrf-rrl, ospC, and dbpA were less conserved: three new ospC and two new dbpA sequence types were found. This genetic heterogeneity reveals that B. spielmanii sp. nov. did not evolve just recently.

Entities:  

Mesh:

Year:  2007        PMID: 17616434     DOI: 10.1016/j.ijmm.2007.05.002

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  57 in total

1.  Whole-genome sequences of Borrelia bissettii, Borrelia valaisiana, and Borrelia spielmanii.

Authors:  Steven E Schutzer; Claire M Fraser-Liggett; Wei-Gang Qiu; Peter Kraiczy; Emmanuel F Mongodin; John J Dunn; Benjamin J Luft; Sherwood R Casjens
Journal:  J Bacteriol       Date:  2012-01       Impact factor: 3.490

2.  Diagnostic use of the lymphocyte transformation test-memory lymphocyte immunostimulation assay in confirming active Lyme borreliosis in clinically and serologically ambiguous cases.

Authors:  Basant K Puri; Daniel Rm Segal; Jean A Monro
Journal:  Int J Clin Exp Med       Date:  2014-12-15

3.  [Cutaneous manifestations of Lyme disease : Pitfalls in the serological diagnostic workup].

Authors:  M Glatz; R R Müllegger
Journal:  Hautarzt       Date:  2017-04       Impact factor: 0.751

4.  In vitro susceptibility of Borrelia spielmanii to antimicrobial agents commonly used for treatment of Lyme disease.

Authors:  Kristina Morgenstern; Georg Baljer; Douglas E Norris; Peter Kraiczy; Christa Hanssen-Hübner; Klaus-Peter Hunfeld
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

5.  Establishment of a minor groove binder-probe based quantitative real time PCR to detect Borrelia burgdorferi sensu lato and differentiation of Borrelia spielmanii by ospA-specific conventional PCR.

Authors:  Christina Strube; Victor M Montenegro; Christian Epe; Elke Eckelt; Thomas Schnieder
Journal:  Parasit Vectors       Date:  2010-08-10       Impact factor: 3.876

6.  Complement factor H-related proteins CFHR2 and CFHR5 represent novel ligands for the infection-associated CRASP proteins of Borrelia burgdorferi.

Authors:  Corinna Siegel; Teresia Hallström; Christine Skerka; Hannes Eberhardt; Barbara Uzonyi; Tobias Beckhaus; Michael Karas; Reinhard Wallich; Brian Stevenson; Peter F Zipfel; Peter Kraiczy
Journal:  PLoS One       Date:  2010-10-20       Impact factor: 3.240

7.  [Lyme borreliosis].

Authors:  A Krause; V Fingerle
Journal:  Z Rheumatol       Date:  2009-05       Impact factor: 1.372

8.  Versatile roles of CspA orthologs in complement inactivation of serum-resistant Lyme disease spirochetes.

Authors:  Claudia Hammerschmidt; Arno Koenigs; Corinna Siegel; Teresia Hallström; Christine Skerka; Reinhard Wallich; Peter F Zipfel; Peter Kraiczy
Journal:  Infect Immun       Date:  2013-11-04       Impact factor: 3.441

9.  Genome sequence of Borrelia afzelii Strain HLJ01, isolated from a patient in China.

Authors:  Bao-Gui Jiang; Yuan-Chun Zheng; Yi-Gang Tong; Na Jia; Qiu-Bo Huo; Hang Fan; Xue-Bing Ni; Lan Ma; X Frank Yang; Jia-Fu Jiang; Wu-Chun Cao
Journal:  J Bacteriol       Date:  2012-12       Impact factor: 3.490

Review 10.  Lyme neuroborreliosis-epidemiology, diagnosis and management.

Authors:  Uwe Koedel; Volker Fingerle; Hans-Walter Pfister
Journal:  Nat Rev Neurol       Date:  2015-07-28       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.